Objectives: To estimate JCV seroprevalence and risk of seroconversion against JCV among MS patients in the Eastern Mediterranean region
Methodology: both a cross-sectional and a longitudinal designs were implemented
MENACTRIMS
MENA Committee for Research and Treatment in Multiple Sclerosis
